News Forte Biosciences, Inc.

Equities

FBRX

US34962G1094

Real-time Estimate Cboe BZX Other stock markets 01:16:32 2024-04-19 pm EDT			5-day change	1st Jan Change
0.759 ^USD	-2.69%		+6.46%	-6.29%

Mar. 18	Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 05	Camac Partners Provides Information to Shareholders	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update	Mar. 18	BU
Camac Partners Provides Information to Shareholders	Jan. 05	CI
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules	Dec. 01	BU
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update	Nov. 13	BU
Forte Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Tocagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Forte Biosciences Filed a Motion to Dismiss the Amended Complaint	23-10-28	CI
Camac Fund Files an Amended Class Action and Derivative Complaint	23-10-20	CI
Declaration of Voting Results by Forte Biosciences	23-09-26	CI
Declaration of Voting Results by Forte Biosciences	23-09-26	CI
Declaration of Voting Results by Forte Biosciences	23-09-26	CI
Declaration of Voting Results by Forte Biosciences	23-09-26	CI
Declaration of Voting Results by Forte Biosciences	23-09-20	CI
Forte Biosciences, Inc. Announces Directorate Appointments	23-09-20	CI
Institutional Shareholder Services and Glass Lewis Support Camac Partners	23-09-14	CI
ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting	23-09-14	BU
Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom	23-09-06	BU
Camac Partners Shares Key Facts that Reinforce the Need for Urgent Change in Forte Biosciences?s Boardroom	23-09-06	CI
Forte Biosciences Issues an Investor Presentation to Shareholders	23-09-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Forte Biosciences, Inc.

Equities

FBRX

US34962G1094

Summary

Filters